New Option for Metastatic Colorectal Cancer: Oxaliplatin and Novel Oral S-1 Combination Chemotherapy

QR Code

New Option for Metastatic Colorectal Cancer: Oxaliplatin and Novel Oral S-1 Combination Chemotherapy

None

Saved in:

Bibliographic Details
Main Author:	Zang, Dae Young
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/21494
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA
by: A. V. Pavlysh, et al.
Published: (2015-03-01)

Oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer patients
by: Dan Kuang, et al.
Published: (2025-07-01)

Combined Oxaliplatin with 5-Fluorouracil for Effective Chemotherapy Against Gastric Cancer in Animal Model
by: Ren J, et al.
Published: (2025-06-01)

DIRAS1 Drives Oxaliplatin Resistance in Colorectal Cancer via PHB1-Mediated Mitochondrial Homeostasis
by: Min Long, et al.
Published: (2025-07-01)

Successful hybrid surgery for ileal conduit stomal varices following oxaliplatin-based chemotherapy in a patient with advanced colorectal cancer
by: Hideo Uehara, et al.
Published: (2020-09-01)

PTEN and p53 Combined Gene Therapy Promote Apoptosis and Chemosensitivity to Oxaliplatin in Colorectal Cancer: An In Vitro Study
by: Narjes Nakhaee, et al.
Published: (2025-04-01)

Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer
by: Reio Ueta, et al.
Published: (2025-07-01)

A Novel Modulator of Resistance for Oxaliplatin-Based Therapy for Colorectal Cancer: The ESCRT Family Member VPS4A
by: Noha M. Abdelrazik, et al.
Published: (2025-06-01)

Efficacy and safety of immunotherapy combined with targeted therapy and chemotherapy in third-line treatment of microsatellite stable metastatic colorectal cancer
by: ZHAO Wensi, et al.
Published: (2025-07-01)

Main aspects of personalized approach to the treatment of patients with chemotherapy resistant metastatic colorectal cancer
by: O. Yu. Stukalova, et al.
Published: (2024-12-01)

Local Therapy of the Primary Tumor: An Option for Metastatic Urothelial Carcinoma in the Era of Novel Combination Therapies?
by: Renate Pichler, et al.
Published: (2025-08-01)

Chemotherapy for Metastatic Disease
by: Sejima, Takehiro, et al.
Published: (2012)

Body mass index on survival in metastatic colorectal cancer patients receiving chemotherapy plus bevacizumab: A meta-analysis
by: Lanqing Peng, et al.
Published: (2025-08-01)

Combination chemotherapy in the treatment of breast cancer patients with metastatic brain involvement and a poor prognosis
by: D. R. Naskhletashvili, et al.
Published: (2014-07-01)

Hepatotoxic chemotherapy of colorectal cancer: state-of-the-art
by: L. O. Polishchuk, et al.
Published: (2009-10-01)

Study of polymorphisms of UGT1A1 and DPYD genes in chemotherapy for colorectal cancer
by: N. N. Timoshkina, et al.
Published: (2019-01-01)

Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer
by: Yu. Yu. Petukhova, et al.
Published: (2021-10-01)

The role of FOLFOXIRI in chemorefractory metastatic colorectal cancer patients
by: Ibrahim Yildiz, et al.
Published: (2018-04-01)

A Biomarker for Metastatic Colorectal Cancer and Treatment Goals
by: Aru W Suydoyo
Published: (2016-05-01)

A Biomarker for Metastatic Colorectal Cancer and Treatment Goals
by: Aru W Suydoyo
Published: (2016-05-01)

Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade
by: Alexander Constantinides, et al.
Published: (2025-09-01)

MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells
by: Hui Liang, et al.
Published: (2019-12-01)

Successful conversion surgery for unresectable gastric cancer with giant para-aortic lymph node metastasis after downsizing chemotherapy with S-1 and oxaliplatin: a case report
by: Akiko Serizawa, et al.
Published: (2018-08-01)

A pathological complete response by chemotherapy with S-1 and oxaliplatin for a locally advanced duodenal adenocarcinoma in Lynch syndrome: a case report
by: Satoshi Yasuda, et al.
Published: (2019-10-01)

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
by: Akira Dejima, et al.
Published: (2023-11-01)

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2019-12-01)

Variability in surgical treatment of metastatic colorectal cancer (literature review)
by: A. Yu. Dobrodeev, et al.
Published: (2023-05-01)

SHORT-TERM RESULTS OF SIMULTANEOUS SURGERIES AT METASTATIC COLORECTAL CANCER
by: A. S. Zagaynov, et al.
Published: (2017-02-01)

MINIMALLY INVASIVE SURGERY IN TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Yu. A. Gevorkyan, et al.
Published: (2020-06-01)

Modern strategy of metastatic colorectal cancer treatment (literature review)
by: O. I. Kit, et al.
Published: (2024-09-01)

The role of image guided ablation in the management of metastatic colorectal cancer
by: Constantinos T. Sofocleous
Published: (2022-12-01)

THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer
by: Xing Zhou, et al.
Published: (2024-12-01)

Folate‐Associated Gene Expression in Primary Tumors Is Associated With Tumor Response and Progression‐Free Survival of Patients With Metastatic Colorectal Cancer Undergoing 5‐FU/Leucovorin‐Based Combination Chemotherapy
by: Elisabeth Odin, et al.
Published: (2025-05-01)

Some aspects of liposomal oxaliplatin formulations
by: A. V. Stadnichenko, et al.
Published: (2015-02-01)

Possibilities of palliative chemotherapy in patients with locally advanced and metastatic pancreatic cancer
by: L. I. Moskvicheva, et al.
Published: (2020-12-01)

Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer
by: Xing Zhou, et al.
Published: (2025-06-01)

Nivolumab monotherapy in metastatic colorectal cancer: current approaches to response evaluation
by: N. N. Babyshkina, et al.
Published: (2022-11-01)

Prognostic Factors Influencing the Efficacy of Regorafenib in the Treatment of Metastatic Colorectal Cancer
by: Nadiye SEVER, et al.
Published: (2025-06-01)

Options for postoperative radiation therapy in patients with de novo metastatic breast cancer
by: Chaofan Li, et al.
Published: (2025-08-01)

A complete response to capecitabine and oxaliplatin chemotherapy in primary duodenal carcinoma with liver and nodal metastases: a case report
by: Seita Hagihara, et al.
Published: (2018-09-01)